Suppliers in West Memphis, AR
9 Medicare Suppliers found. Showing 1 - 9
 Caldwell Home Medical Llc Durable Medical Equipment & Medical Supplies Location: 648 W Broadway St, West Memphis, Arkansas 72301 Phone: (870) 733-1010 |
Walgreens #2774 Durable Medical Equipment & Medical Supplies Location: 346 W Broadway St, West Memphis, Arkansas 72301 Phone: (870) 733-0138 |
Walmart Pharmacy 10-0070 Durable Medical Equipment & Medical Supplies Location: 798 W Service Rd, West Memphis, Arkansas 72301 Phone: (870) 735-2324 |
Kroger Pharmacy 469 Durable Medical Equipment & Medical Supplies Location: 300 Interstate 40 Service Rd, West Memphis, Arkansas 72301 Phone: (870) 732-0283 |
Walgreens #5789 Durable Medical Equipment & Medical Supplies Location: 1800 N Missouri St Ste 2, West Memphis, Arkansas 72301 Phone: (870) 735-8987 |
Bradley Foot Care Medicare Supplier Location: 116 West Tyler Avenue, West Memphis, Arkansas 72301 Phone: (870) 733-0888 |
Vrf Eye Specialty Group, Plc Medicare Supplier Location: 1028 N Missouri St, West Memphis, Arkansas 72301 Phone: (870) 735-8466 |
Dr Charles F Hyman Durable Medical Equipment & Medical Supplies Location: 1028 N Missouri St, West Memphis, Arkansas 72301 Phone: (870) 735-8466 |
Dr Julie T Caldwell Od Pa Medicare Supplier Location: 201 S Avalon St, West Memphis, Arkansas 72301 Phone: (870) 732-4701 |
News Archive
Lafora rare disease could be aggravated by oxidative stress
Neurodegenerative Lafora disease usually becomes apparent through seizures during adolescence and puberty and occurs as a consequence of defects in glycogen metabolism and in the cellular mechanisms that are responsible for its disposal. Researchers at the University of Valencia have led a study in which they propose that Lafora rare disease could be aggravated by oxidative stress.
Updated phase II study results of OPAXIO in patients with advanced esophageal cancer
Cell Therapeutics, Inc. announced today that updated phase II study results of OPAXIO (paclitaxel poliglumex) in patients with advanced esophageal cancer demonstrated that 38% (15/40) patients receiving OPAXIO in combination with cisplatin and concurrent radiation achieved a pathologic or endoscopic complete response.
Delirium overlooked in hospital patients
Delirium occurs in about one in five inpatients, but appears to be a low priority with hospital staff, research suggests.
U.S. must maintain commitment to research outlined in AIDS blueprint
Noting the recent release of the "PEPFAR Blueprint: Creating an AIDS-free Generation", Kim Lufkin, communications officer at the Global Health Technologies Coalition (GHTC), writes in the organization's "Breakthroughs" blog, "It's commendable that the U.S. government is continuing its legacy as a leader in the fight against HIV/AIDS, as this blueprint indicates.
› Verified 5 days ago